
MSF warns high prices of tuberculosis drugs restrict people´s access to best drug-resistant TB treatment
We call on US pharma corporation Johnson & Johnson to cut key TB drug price in half The Hague — People with drug-resistant tuberculosis (DR-TB) continue to be deprived of today’s best-possible treatment in part